These approaches include targeting key signaling pathways such as TGF-β [12, 13], Hedgehog [14], and Wnt/β-catenin [15], which are known to regulate CAF activation and their subsequent contributions to tumor progression. The gene discussed is TGFB1; the disease is neoplasm.